About
GeneDx provides advanced genetic testing solutions designed to accelerate the diagnosis of rare and inherited conditions. Recognized as the #1 genetic test by pediatric and genetic specialists, GeneDx is trusted by more than 75,000 clinicians worldwide. Their testing portfolio spans whole genome sequencing (WGS), whole exome sequencing (WES), targeted panels, and prenatal genetic testing, supporting a wide range of specialties including pediatric neurology, general pediatrics, and neonatal critical care. At the core of GeneDx's offering is GeneDx Infinity™, a platform built on 2.5+ million genetic tests, nearly 1 million sequenced exomes and genomes, and 8 million phenotypic data points. This unmatched dataset—combined with AI and clinical expertise—enables diagnostic yields 17% greater than standard testing, with results delivered within days or weeks. Most tests accept a simple cheek swab with at-home sample collection available. GeneDx serves multiple segments: providers seeking earlier, data-driven diagnoses; patients and families looking for answers to complex conditions; health systems integrating precision medicine at scale; and biopharma companies accelerating drug discovery and clinical trials. With industry-leading variant classification, clearly written reports, genetic counselor support, and EHR integration via Epic Aura, GeneDx streamlines the entire genetic testing workflow. Approximately 60% of individuals who receive a genomic sequencing diagnosis experience a change in medical management, underscoring the actionable impact of GeneDx's results.
Key Features
- Whole Exome & Genome Sequencing: Comprehensive genomic sequencing options including WES and WGS covering ~20,000 genes, with results delivered within days or weeks using minimally invasive cheek swab samples.
- GeneDx Infinity™ Dataset: One of the largest rare disease datasets in the world, with 2.5+ million genetic tests, ~1 million exomes/genomes, and 8 million phenotypic data points powering AI-driven diagnoses.
- AI-Powered Variant Classification: Industry-leading classification system combines AI with clinical expertise to deliver diagnostic yields 17% greater than standard genetic testing.
- EHR Integration & Clinical Support: Seamless Epic Aura EHR integration, genetic counselor support, and clearly written reports make results immediately actionable within clinical workflows.
- Broad Test Portfolio: Includes targeted panels, prenatal genetic testing, rapid and ultraRapid testing options, and specialty-specific workflows for pediatric neurology, epilepsy, autism, and more.
Use Cases
- Clinicians ordering genetic testing to diagnose children with epilepsy, autism, global developmental delay, or other neurodevelopmental conditions.
- Neonatal and pediatric intensive care teams using rapid whole genome sequencing to identify the cause of critical illness in newborns.
- Genetic counselors and geneticists evaluating patients with suspected rare or inherited disorders across ~20,000 genes.
- Biopharma researchers leveraging GeneDx Infinity™ genomic data to identify patient populations, biomarkers, and therapeutic targets for rare disease drug development.
- Health systems implementing precision medicine programs at scale with integrated genomic sequencing and EHR-connected reporting.
Pros
- Unmatched Rare Disease Dataset: GeneDx Infinity™ draws on 2.5+ million tests and 8 million phenotypic data points, providing deeper insights than virtually any competing platform.
- Superior Diagnostic Yield: Achieves 17% greater diagnostic yield than standard testing, and 60% of diagnosed patients experience a change in medical management based on results.
- Fast, Simple Sample Collection: Most tests accept a simple cheek swab with at-home collection available, minimizing patient burden and enabling rapid turnaround.
- End-to-End Clinical Integration: Epic Aura EHR integration, billing/insurance support, and genetic counseling streamline the full testing journey for both providers and patients.
Cons
- Primarily a Clinical Service: GeneDx is a specialized clinical testing service rather than a self-serve software tool, requiring provider orders and clinical oversight for most tests.
- Cost and Insurance Complexity: Genetic testing costs can be significant, and insurance coverage varies, which may present financial barriers for some patients despite available assistance programs.
- Not a Consumer-Direct Platform: Access is primarily through healthcare providers, making it less accessible for individuals seeking direct-to-consumer genetic insights.
Frequently Asked Questions
GeneDx offers whole genome sequencing (WGS), whole exome sequencing (WES), targeted gene panels, prenatal genetic testing, and rapid/ultraRapid sequencing for critical care settings, covering a wide range of rare and inherited conditions.
Turnaround times vary by test type. Standard exome and genome sequencing typically delivers results within weeks, while rapid and ultraRapid options are designed for urgent clinical scenarios and can return results in days.
GeneDx Infinity™ is GeneDx's proprietary genomic intelligence platform, built on 2.5+ million genetic tests, nearly 1 million exomes and genomes, and 8 million phenotypic data points. It combines this dataset with AI and clinical expertise to accelerate rare disease diagnoses and support drug discovery.
GeneDx provides biopharma partners with access to deep genomic data and rare disease insights to accelerate drug discovery, biomarker identification, and clinical trial design through the GeneDx Infinity™ platform.
Yes. GeneDx offers Epic Aura EHR integration, enabling seamless ordering, results delivery, and workflow management within existing clinical systems.
